The Power of Open Accessibility in Science

Paul: Even for example in a commercializable space of biotechs it's extremely siloed and like very hard to get insights and access to kind of like research. With VITADAR what I think is actually one of the biggest powers is that a lot of things have been reopened, he says. Paul: There was an executive order by the president I'm not sure on making all state funded research by nature and needs to be now open accessible from next year. molecule began two and a half years ago thinking if we can bring liquidity much earlier into the development pipeline then that could unlock a huge amount of innovation according to Laptau.

Transcript

Play full episode

Transcript

Episode notes

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app